SOLUBLE EPOXIDE HYDROLASE INHIBITORS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT
申请人:Colletti Steven L.
公开号:US20100197691A1
公开(公告)日:2010-08-05
Compounds of the Formula: (I) as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating hypertension, diabetes, inflammation, atherosclerosis, pain, and the like are disclosed. Pharmaceutical compositions and methods of use are also included.
US8455520B2
申请人:——
公开号:US8455520B2
公开(公告)日:2013-06-04
[EN] SOLUBLE EPOXIDE HYDROLASE INHIBITORS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT<br/>[FR] INHIBITEURS ÉPOXYDE HYDROLASE SOLUBLES, COMPOSITIONS CONTENANT DE TELS COMPOSÉS ET PROCÉDÉS DE TRAITEMENT
申请人:MERCK & CO INC
公开号:WO2009011872A1
公开(公告)日:2009-01-22
Compounds of the Formula: (I) as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating hypertension, diabetes, inflammation, atherosclerosis, pain, and the like are disclosed. Pharmaceutical compositions and methods of use are also included.
BUCHANAN G. L., J. CHEM. SOC. CHEM. COMMUN., 1981, NO 15, 814-815
作者:BUCHANAN G. L.
DOI:——
日期:——
BUCHANAN, G. L., J. CHEM. SOC. PERKIN TRANS., 1984, N 11, 2669-2670